A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PA / psoriatic arthritis

[Related PubMed/MEDLINE]
Total Number of Papers: 111
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PA  (>> Co-occurring Abbreviation)
Long Form:   psoriatic arthritis
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Double infection in a patient with psoriatic arthritis under TNF-alpha blockers therapy: a case report. HRCT, TNF
2019 Persistence with biological drugs in patients treated in rheumatology practices in Germany. AS, CI, HR, RA
2018 The clinical diagnostic significance of auto antibodies to CD74 at axial spondylarthritis. AS, axSpA, nr-axSpA
2017 Association between mean platelet volume and disease severity in patients with psoriasis and psoriatic arthritis. MPV, PASI, PV
2017 Features of some clinical examination parameters in patients with psoriatic arthritis. ---
2017 Temporomandibular joint involvement in psoriatic arthritis. TMJ
2016 Autologous Adipose-Derived Mesenchymal Stromal Cells for the Treatment of Psoriasis Vulgaris and Psoriatic Arthritis: A Case Report. MSCs, PASI, PV, ROS, TNF-alpha
2015 Use of a validated screening tool for psoriatic arthritis in dermatology clinics. PEST
2014 Infection risk in rheumatoid arthritis and spondyloarthropathy patients under treatment with DMARDs, corticosteroids and TNF-alpha antagonists. AS, CS, DMARDs, IR, IRR, RA, SpA, TNF
10  2014 Osteoarthritis and psoriatic arthritis: findings in three-dimensional biophotonics imaging. DIP, DOT, OA
11  2014 Screening for latent tuberculosis infection in psoriasis and psoriatic arthritis patients in a tuberculosis-endemic country: a comparison of the QuantiFERON-TB Gold In-Tube test and tuberculin skin test. BCG, HIV, QFT-GIT, TB, TST
12  2012 Human leukocyte antigen-b27 and disease susceptibility in vojvodina, serbia. AAU, AS, EF, HLAs, PF, RA, RR
13  2012 [Expression of Th17/Treg cell in patients with psoriasis arthritis and its clinical significance]. ELISA
14  2012 [Monocytic parameters in patients with rheumatologic diseases reflect intensity of depressive disorder]. AS, BDI, CSS, HAMD, IL-1beta, IL-6, IL-8, RA, SLE, TNF-alpha
15  2011 Coexistence of polyarteritis nodosa and psoriatic arthritis in a child: an unreported association: Polyarteritis nodosa and Psoriatic arthitritis. PAN
16  2011 Low prevalence of reactive PPD prior to infliximab use: comparative study on a population sample of Hospital Geral de Fortaleza. AS, RA
17  2011 Markedly elevated serum levels of calcium-binding S100A8/A9 proteins in psoriatic arthritis are due to activated monocytes/macrophages. ---
18  2011 Participation, satisfaction and knowledge level of patients with cutaneous psoriasis or psoriatic arthritis. CP
19  2011 [Cardiovascular risk factors in psoriatic and rheumatoid arthritis]. AH, RA, TIM
20  2010 Abatacept as an option therapy in difficult to treat psoriatic arthritis. ---
21  2010 Differing patterns of peripheral blood leukocyte telomere length in rheumatologic diseases. AS, OA, OP, PBL, qPCR, RA
22  2010 Psoriatic arthritis: temporomandibular joint involvement as the first articular phenomenon. TMJs
23  2010 Use of the abatacept in a patient with psoriatic arthritis. ---
24  2010 [Adverse effects of cyclosporin a observed in rheumatoid arthritis and psoriatic arthritis]. CsA, MTX, RA
25  2010 [LE cells in synovial fluid: prevalence and diagnostic usefulness in rheumatic diseases]. ANA, AS, RA, SLE, SS
26  2010 [Psoriatic arthritis and etanercept]. DMARD
27  2009 Genetic variants of the IL-23R pathway: association with psoriatic arthritis and psoriasis vulgaris, but no specific risk factor for arthritis. PSORS1, PV
28  2009 [Cardiovascular risk in psoriatic arthritis]. ---
29  2008 Antibodies to carbonic anhydrase in patients with connective tissue diseases: relationship with lung involvement. ACAI and ACAII, AS, CTD, HRCT, RA, SLE, SS, SSc
30  2008 Cerebral MRI lesions and anti-tumor necrosis factor-alpha therapy. anti-TNF-alpha, AS, MRI
31  2007 Administration of infliximab in general practitioners' offices is safe. AE, AS, CD, GPs, RA, SAE
32  2007 Psoriatic arthritis-associated polyneuropathy: a report of three cases. ---
33  2006 Analysis of polymorphisms in 16 genes in type 1 diabetes that have been associated with other immune-mediated diseases. GD, INS, MAF, MS, OR, RA, RR, SLE, SNPs, T1D
34  2006 [Tuberculosis in rheumatic patients treated with tumour necrosis factor alpha antagonists: the Portuguese experience]. AS, RA, TB, TST
35  2006 [Ultrasound features of entesopathy in patients with psoriatic dactylitis]. RA
36  2005 The prevalence of temporomandibular disorders in patients with psoriasis with or without psoriatic arthritis. Ai, Di, TMD
37  2005 [Psoriatic arthritis: combined treatment with prospidin and methotrexate]. ---
38  2004 Characterization and recruitment of plasmacytoid dendritic cells in synovial fluid and tissue of patients with chronic inflammatory arthritis. DCs, OA, pDCs, RA, SF
39  2004 MMP-2, MMP-9, TIMP-1 and TIMP-2 levels in patients with rheumatoid arthritis and psoriatic arthritis. ECM, MMPs, RA
40  2004 [3H]PK11195 binding sites in human neutrophils: effect of fMLP stimulation and modulation in rheumatic diseases. fMLP, OA, PBR, RA
41  2004 [The heart damage in patients with psoriatic arthritis]. ---
42  2003 Peripheral-type benzodiazepine receptors in human mononuclear cells of patients affected by osteoarthritis, rheumatoid arthritis or psoriasic arthritis. OA, PBR, RA
43  2002 Grading of chronic synovitis--a histopathological grading system for molecular and diagnostic pathology. OA, RA, ReA
44  2002 IgVH-genes analysis from psoriatic arthritis shows involvement of antigen-activated synovial B-lymphocytes. CDR, FR
45  2001 Ultrasound measurements at the proximal phalanges in male patients with psoriatic arthritis. AD-SoS, AS, RA, UBPS
46  2000 Mig, GRO alpha and RANTES messenger RNA expression in lining layer, infiltrates and different leucocyte populations of synovial tissue from patients with rheumatoid arthritis, psoriatic arthritis and osteoarthritis. OA, RA
47  2000 [Differential diagnosis of chronic urogenic arthritis]. AS, CUA
48  2000 [Hyperaggregation syndrome in patients with osteolytic psoriatic arthritis]. ---
49  1999 Antiperinuclear factor in psoriatic arthropathy. APF, RF
50  1999 Synovitis of small joints: sonographic guided diagnostic and therapeutic approach. ---
51  1999 [The effect of carbon dioxide baths and applications of low-temperature peloids on the immune function of patients with psoriatic arthritis]. ---
52  1998 Bilateral shoulder pain: psoriatic arthritis masquerading as overuse. ---
53  1998 Corticosteroid prescribing in rheumatoid arthritis and psoriatic arthritis. RA
54  1998 Psoriatic arthritis associated with dilated cardiomyopathy and Takayasu's arteritis. ---
55  1998 The relationship between serum-soluble interleukin-2 receptor and radiological evolution in psoriatic arthritis patients treated with cyclosporin-A. CsA, sIL-2R
56  1997 Antibodies to streptococcal cell wall in psoriatic arthritis and cutaneous psoriasis. NAP, PG, PG-PS, RA
57  1997 Interactions of lymphocytes from patients with psoriatic arthritis or healthy controls and cultured endothelial cells. EC, FC, HUVEC, LC, MoAbs
58  1996 Significance of antibodies to streptococcal M protein in psoriatic arthritis and their association with HLA-A*0207. ---
59  1995 Immunolocalization of adhesion molecules in psoriatic arthritis, psoriatic and normal skin. ELAM-1, ICAM-1, Ps, RA, VCAM-1
60  1995 Vertical asymmetry of the mandibular ramus and condylar heights measured with a new method from dental panoramic radiographs in patients with psoriatic arthritis. CO
61  1994 A radioreceptor assay for TNF alpha-binding proteins. ELISAs, OA, RA, sTNFR, TNF-alpha
62  1994 Immunohistochemical markers for arthritis in psoriasis. ---
63  1994 Interrelationships between interleukin (IL)-1, IL-6 and IL-8 in synovial fluid of various arthropathies. IL, OA, RA, SF, TP, WBC
64  1994 [The efficacy of diclonate P in psoriatic arthritis]. ---
65  1993 Low molecular weight IgM in primary Sjogren's syndrome. LMW IgM, RA
66  1993 Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. ELAM-1, ICAM-1, RA, SM, VCAM-1
67  1993 Therapeutic efficacy of oral low-dose cyclosporin A in severe psoriatic arthritis. ---
68  1992 Anti-enterobacteria antibodies in psoriatic arthritis. CF, Cj, CT, HD, NAP, RA, YPT
69  1992 Double disease in rheumatology: coexistence of rheumatoid arthritis and psoriatic arthritis. RA
70  1992 Dyslipoproteinemia in the course of active rheumatoid arthritis. HDL, MA, OA, RA, SA
71  1992 Immunohistochemical analysis of synovial membranes from inflammatory and non-inflammatory arthritides: scarcity of CD5 positive B cells and IL2 receptor bearing T cells. IL-2R, OA, RA, RS
72  1992 Multiple cervical cord compressions in psoriatic arthritis. AAS
73  1992 Nailfold capillary permeability in psoriatic arthritis. ---
74  1992 Psoriatic arthritis (PA): a harmless disease? ---
75  1992 [The comparative efficacy of slow-acting (basic) preparations in psoriatic arthritis]. Chr, MT, NSAID, SSD
76  1991 Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients. DIP
77  1991 Radiographic signs in the temporomandibular and hand joints in patients with psoriatic arthritis. ---
78  1991 [How to choose a basic drug for psoriatic arthritis?]. DMARDs, ESR, MS, PASI, VAS
79  1991 [The treatment of severe psoriatic arthritis with methotrexate in a weekly "mini-pulse" dosage plan]. MTX
80  1990 Comparison of three radiographic methods in screening of temporomandibular joint involvement in patients with psoriatic arthritis. TMJ
81  1990 ELISA determined IgM and IgA rheumatoid factors in seronegative rheumatoid and psoriatic arthritis. ELISA, RA, RF's
82  1990 The presence of autoantibody to recombinant lipocortin-I in patients with psoriasis and psoriatic arthritis. ALA, ELISA
83  1990 [Rhythm profile in patients with psoriatic arthritis]. pts
84  1989 Antinuclear antibodies in psoriatic arthritis and its subgroups. ANA
85  1989 Clinical response to auranofin in patients with psoriatic arthritis. AF
86  1989 Serum osteocalcin as an index of bone turnover in active rheumatoid arthritis and in active psoriatic arthritis. RA
87  1989 [Enthesopathic reactions of the wrist in psoriatic arthritis, chronic polyarthritis and diffuse idiopathic skeletal hyperostosis. Results based on 3-dimensional soft radiographs]. DISH, RA
88  1988 Antibacterial antibody pattern in seronegative spondyloarthropathies (SNSA). AS, CI, Cj, CT, EA, HD, RA, SNSA, U-SNSA, YPT
89  1988 Humoral immunity to link protein in patients with inflammatory joint disease, osteoarthritis, and in non-arthritic controls. AS, ELISA, OA, RA, SLE
90  1988 The influence of synovial fluids from patients with rheumatic diseases on chick embryo fibroblasts. GAG, OA, PCEF, RA
91  1988 [Blood cell concentration of methotrexate in long-term therapy of inflammatory rheumatic diseases]. MTX, RA
92  1987 Carboxypeptidase N (kininase I) activity in blood and synovial fluid from patients with arthritis. OA, RA, SF
93  1987 Clinical signs of craniomandibular disorders patients with psoriatic arthritis. CM
94  1987 Indices of disease activity in psoriatic arthritis. DIPjs, ESR, RA
95  1987 Laboratory features of psoriatic arthritis. RA
96  1987 Marked increase in the frequency of psoriatic arthritis in psoriasis patients with HLA-DR+ keratinocytes. KTC
97  1987 Mitral valve prolapse (MVP) in psoriatic arthritis (PA) MVP
98  1987 Radiographic changes in the condyle of the temporomandibular joint in psoriatic arthritis. TMJ
99  1987 Work capacity of patients with inflammatory joint diseases. An eight-year follow-up study. AS, RA, ReA, SO
100  1986 Alpha 1-antitrypsin in acute anterior uveitis and rheumatic diseases. AAU, AS, PI, RA, RD